Blackstone announces final close of $6.3B Blackstone Life Sciences VI fund

Blackstone (BX) announced the final close of Blackstone Life Sciences VI. BXLS VI was oversubscribed and closed at its hard cap of $6.3B of total capital commitments. It is the largest life sciences private fund ever raised and is nearly 40% larger than its predecessor vehicle. Nicholas Galakatos, Global Head of Blackstone Life Sciences, said, “We are grateful to the BXLS VI investors for their strong support of our strategies and the firm’s enduring conviction in the life sciences.” He added, “Our partnerships with global leaders have produced 34 regulatory approvals of innovative medicines and devices. This track record highlights how we work successfully with industry trailblazers to help bring their most important products to patients around the world.”